Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?
M Giannini, M Ohana, B Nespola… - European …, 2020 - Eur Respiratory Soc
M Giannini, M Ohana, B Nespola, G Zanframundo, B Geny, A Meyer
European Respiratory Journal, 2020•Eur Respiratory SocAs yet, no direct-acting antiviral drugs have demonstrated efficacy in the disease. In contrast,
increasing evidence indicates an immune-mediated pathophysiology that is paving the way
for the evaluation of immunomodulation strategies [2]. In support of this view, we would like
to highlight the striking similarities between COVID-19 and a rare autoimmune disease: the
anti-MDA5-syndrome.
increasing evidence indicates an immune-mediated pathophysiology that is paving the way
for the evaluation of immunomodulation strategies [2]. In support of this view, we would like
to highlight the striking similarities between COVID-19 and a rare autoimmune disease: the
anti-MDA5-syndrome.
As yet, no direct-acting antiviral drugs have demonstrated efficacy in the disease. In contrast, increasing evidence indicates an immune-mediated pathophysiology that is paving the way for the evaluation of immunomodulation strategies [2]. In support of this view, we would like to highlight the striking similarities between COVID-19 and a rare autoimmune disease: the anti-MDA5-syndrome.
European Respiratory Society